MEDIKINET MR 20 MG MODIFIED-RELEASE CAPSULES

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

METHYLPHENIDATE HYDROCHLORIDE 20 MG

Disponible desde:

MEDILINE LTD.

Código ATC:

N06BA04

formulario farmacéutico:

MODIFIED RELEASE CAPSULES

Vía de administración:

PER OS

Fabricado por:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

Grupo terapéutico:

METHYLPHENIDATE

indicaciones terapéuticas:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

Fecha de autorización:

2011-05-01